Management of Pediatric Pancreatic Calculi At a Single Center: a Retrospective Cohort Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: ERCP.
- Who it may be relevant to
- Registry conditions: Pancreatic Duct Stenting, ERCP, Surgery in Early Childhood, Pediatric Surgery. Basic parameters: 2 months — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Single-Center Retrospective Cohort Study Evaluating the Management and Outcomes of Pediatric Pancreatic Duct Stones Using Endoscopic and Surgical Techniques
Overview
The goal of this observational study is to evaluate the long-term effects of ERCP and surgery in pediatric patients with pancreatic duct stones. The main objective is to determine the optimal treatment choice(ERCP or surgery) for children with pancreatic duct stones and identify the appropriate timing for surgery in patients who have undergone multiple ERCP procedures, in order to avoid adverse outcomes caused by repeated trauma to the duodenal papilla. Last updated on January 24, 2025.
Interventions
- Procedure ERCP
There are two intervention methods for pediatric pancreatic duct stones. One is to remove the pancreatic duct stones through Endoscopic Retrograde Cholangiopancreatography(ERCP), while simultaneously dilating the pancreatic duct and placing a stent to assist in the normal drainage of pancreatic juice. The other is local resection of the pancreatic head combined with longitudinal pancreaticojejunostomy (Frey surgery).
Primary outcome measures
- stone clearance [Time frame: From intervention to the end of treatment at 1 week]
- complication rate [Time frame: From enrollment to the end of treatment at 2 weeks]
- reintervention rate [Time frame: From enrollment to the end of treatment at 1 year.]
Eligibility criteria
Inclusion criteria
- Patients aged 0 to 18 years
- Diagnosed with pancreatic duct stones by imaging (e.g., ultrasound, CT, MRCP)
- Treated and followed at pediatric surgery, west china hospital, between 2014 and 2025
- Complete clinical data available for review
Exclusion criteria
- Pancreatic duct stones secondary to previous pancreatic or biliary surgery
- Concurrent severe systemic diseases (e.g., advanced cardiac, renal, or hepatic disease)
- Incomplete or missing key clinical records
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06900790 · Ethical No. 2024 Review (35)